{"transactions":[{"id":768419,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-21T20:36:24.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":1660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual equity award in the form of restricted stock units (\"RSUs\").  These RSUs, which will be settled in shares of common stock on a one-for-one basis, vest in full on April 30, 2027."}],"balance_after":2438,"source":{"system":"sec-edgar","filing":"0001145197-26-000126","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000114519726000126/form4.xml","form_type":"4"}},{"id":880099,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-02-26T12:05:23.000Z","date":"2026-02-25","kind":"purchase","planned":false,"acquired":true,"shares":2030,"price":246.23,"value":499846.9,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average purchase price of the shares acquired. The shares were purchased in multiple transactions at prices ranging from $246.04 to $246.42. The Reporting Person hereby undertakes, upon the request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":17483,"source":{"system":"sec-edgar","filing":"0001145197-26-000044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000114519726000044/form4.xml","form_type":"4"}},{"id":1059499,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-21T20:11:33.000Z","date":"2025-08-21","kind":"gift","planned":false,"acquired":true,"shares":1380,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse.  The reporting person's spouse is a trustee of the trust."}],"balance_after":15453,"source":{"system":"sec-edgar","filing":"0001145197-25-000046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000114519725000046/form4.xml","form_type":"4"}},{"id":1059498,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-21T20:11:33.000Z","date":"2025-08-21","kind":"gift","planned":false,"acquired":false,"shares":1380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse.  The reporting person's spouse is a trustee of the trust."}],"balance_after":778,"source":{"system":"sec-edgar","filing":"0001145197-25-000046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000114519725000046/form4.xml","form_type":"4"}},{"id":1059497,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-21T20:11:33.000Z","date":"2025-08-19","kind":"gift","planned":false,"acquired":true,"shares":9459,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse.  The reporting person's spouse is a trustee of the trust."}],"balance_after":14073,"source":{"system":"sec-edgar","filing":"0001145197-25-000046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000114519725000046/form4.xml","form_type":"4"}},{"id":1059496,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-21T20:11:33.000Z","date":"2025-08-19","kind":"gift","planned":false,"acquired":false,"shares":9459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse.  The reporting person's spouse is a trustee of the trust."}],"balance_after":2158,"source":{"system":"sec-edgar","filing":"0001145197-25-000046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000114519725000046/form4.xml","form_type":"4"}},{"id":1059495,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-21T20:11:33.000Z","date":"2025-08-19","kind":"gift","planned":false,"acquired":true,"shares":9459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the transfer of common stock from the GRAT to the reporting person."}],"balance_after":11617,"source":{"system":"sec-edgar","filing":"0001145197-25-000046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000114519725000046/form4.xml","form_type":"4"}},{"id":1059494,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-21T20:11:33.000Z","date":"2025-08-19","kind":"gift","planned":false,"acquired":false,"shares":9459,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GRAT"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the transfer of common stock from the GRAT to the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001145197-25-000046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000114519725000046/form4.xml","form_type":"4"}},{"id":1133792,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-27T20:08:24.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual equity award in the form of restricted stock units (\"RSUs\"). These RSUs, which will be settled in shares of common stock on a one-for-one basis, vest in full on April 30, 2026."}],"balance_after":2158,"source":{"system":"sec-edgar","filing":"0001127602-25-015651","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760225015651/form4.xml","form_type":"4"}},{"id":1490456,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-05T20:15:37.000Z","date":"2024-06-04","kind":"gift","planned":false,"acquired":true,"shares":843,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse.  The reporting person's spouse is a trustee of the trust."}],"balance_after":4614,"source":{"system":"sec-edgar","filing":"0001127602-24-017916","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760224017916/form4.xml","form_type":"4"}},{"id":1490455,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-05T20:15:37.000Z","date":"2024-06-04","kind":"gift","planned":false,"acquired":false,"shares":843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse.  The reporting person's spouse is a trustee of the trust."}],"balance_after":1380,"source":{"system":"sec-edgar","filing":"0001127602-24-017916","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760224017916/form4.xml","form_type":"4"}},{"id":1504015,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-23T21:10:34.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":1380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual equity award in the form of restricted stock units (\"RSUs\"). These RSUs vest in full on April 30, 2025 and are settled in shares of common stock on a one-for-one basis."}],"balance_after":2223,"source":{"system":"sec-edgar","filing":"0001127602-24-016460","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760224016460/form4.xml","form_type":"4"}},{"id":1802145,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-18T20:26:48.000Z","date":"2023-08-18","kind":"gift","planned":false,"acquired":true,"shares":8450,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GRAT"},"balance_after":9459,"source":{"system":"sec-edgar","filing":"0001127602-23-022944","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760223022944/form4.xml","form_type":"4"}},{"id":1802144,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-18T20:26:48.000Z","date":"2023-08-18","kind":"gift","planned":false,"acquired":false,"shares":8450,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":3771,"source":{"system":"sec-edgar","filing":"0001127602-23-022944","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760223022944/form4.xml","form_type":"4"}},{"id":1802143,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-18T20:26:48.000Z","date":"2023-08-17","kind":"gift","planned":false,"acquired":true,"shares":1009,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GRAT"},"balance_after":1009,"source":{"system":"sec-edgar","filing":"0001127602-23-022944","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760223022944/form4.xml","form_type":"4"}},{"id":1802142,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-18T20:26:48.000Z","date":"2023-08-17","kind":"gift","planned":false,"acquired":false,"shares":1009,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":843,"source":{"system":"sec-edgar","filing":"0001127602-23-022944","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760223022944/form4.xml","form_type":"4"}},{"id":1880004,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-24T20:11:26.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Annual equity award in the form of restricted stock units (\"RSUs\").  These RSUs vest in full on April 30, 2024 and are settled in shares of common stock on a one-for-one basis."}],"balance_after":1852,"source":{"system":"sec-edgar","filing":"0001127602-23-016714","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760223016714/form4.xml","form_type":"4"}},{"id":1880003,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-24T20:11:26.000Z","date":"2023-05-23","kind":"purchase","planned":false,"acquired":true,"shares":3300,"price":304.75,"value":1005675.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average purchase price of the shares bought.  The shares were bought at varying prices in the range of $304.68 to $304.75.  The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":12221,"source":{"system":"sec-edgar","filing":"0001127602-23-016714","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760223016714/form4.xml","form_type":"4"}},{"id":2076422,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Performance Stock Units","published_at":"2022-12-27T17:55:49.000Z","date":"2022-12-22","kind":"disposition_to_issuer","acquired":false,"shares":96265,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Pursuant to the Merger Agreement, each award of restricted stock units with vesting subject to performance-based conditions (\"Company PSU Award\") outstanding immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of December 22, 2022 (the \"Closing Date\") and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as of the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance)"},{"field":"kind","element":"transactionCoding","label":"F7","text":"and (B) the Cash Amount, and (ii) one CVR for each Issuer Share underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of the Closing Date and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance))."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, each award of restricted stock units with vesting subject to performance-based conditions (\"Company PSU Award\") outstanding immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of December 22, 2022 (the \"Closing Date\") and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as of the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance)"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"and (B) the Cash Amount, and (ii) one CVR for each Issuer Share underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of the Closing Date and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance))."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Merger Agreement, each award of restricted stock units with vesting subject to performance-based conditions (\"Company PSU Award\") outstanding immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of December 22, 2022 (the \"Closing Date\") and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as of the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"and (B) the Cash Amount, and (ii) one CVR for each Issuer Share underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of the Closing Date and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance))."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Pursuant to the Merger Agreement, each award of restricted stock units with vesting subject to performance-based conditions (\"Company PSU Award\") outstanding immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of December 22, 2022 (the \"Closing Date\") and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as of the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance)"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"and (B) the Cash Amount, and (ii) one CVR for each Issuer Share underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of the Closing Date and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance))."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":96265},"source":{"system":"sec-edgar","filing":"0001415889-22-013017","document":"form4-12272022_101240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013017/form4-12272022_101240.xml","form_type":"4"}},{"id":2076421,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Performance Stock Units","published_at":"2022-12-27T17:55:49.000Z","date":"2022-12-22","kind":"grant","acquired":true,"shares":96265,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Pursuant to the Merger Agreement, each award of restricted stock units with vesting subject to performance-based conditions (\"Company PSU Award\") outstanding immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of December 22, 2022 (the \"Closing Date\") and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as of the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance)"},{"field":"kind","element":"transactionCoding","label":"F7","text":"and (B) the Cash Amount, and (ii) one CVR for each Issuer Share underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of the Closing Date and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance))."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, each award of restricted stock units with vesting subject to performance-based conditions (\"Company PSU Award\") outstanding immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of December 22, 2022 (the \"Closing Date\") and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as of the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance)"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"and (B) the Cash Amount, and (ii) one CVR for each Issuer Share underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of the Closing Date and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance))."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Merger Agreement, each award of restricted stock units with vesting subject to performance-based conditions (\"Company PSU Award\") outstanding immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of December 22, 2022 (the \"Closing Date\") and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as of the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"and (B) the Cash Amount, and (ii) one CVR for each Issuer Share underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of the Closing Date and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance))."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Pursuant to the Merger Agreement, each award of restricted stock units with vesting subject to performance-based conditions (\"Company PSU Award\") outstanding immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of December 22, 2022 (the \"Closing Date\") and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as of the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance)"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"and (B) the Cash Amount, and (ii) one CVR for each Issuer Share underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of the Closing Date and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance))."}],"balance_after":96265,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":96265},"source":{"system":"sec-edgar","filing":"0001415889-22-013017","document":"form4-12272022_101240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013017/form4-12272022_101240.xml","form_type":"4"}},{"id":2076420,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-27T17:55:49.000Z","date":"2022-12-22","kind":"disposition_to_issuer","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"kind","element":"transactionCoding","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":283.88,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-22-013017","document":"form4-12272022_101240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013017/form4-12272022_101240.xml","form_type":"4"}},{"id":2076419,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-27T17:55:49.000Z","date":"2022-12-22","kind":"disposition_to_issuer","acquired":false,"shares":20898,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"kind","element":"transactionCoding","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":223.9,"expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":20898},"source":{"system":"sec-edgar","filing":"0001415889-22-013017","document":"form4-12272022_101240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013017/form4-12272022_101240.xml","form_type":"4"}},{"id":2076418,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-27T17:55:49.000Z","date":"2022-12-22","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"kind","element":"transactionCoding","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":266.39,"expiration_date":"2029-05-30","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-22-013017","document":"form4-12272022_101240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013017/form4-12272022_101240.xml","form_type":"4"}},{"id":2076417,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-12-27T17:55:49.000Z","date":"2022-12-22","kind":"disposition_to_issuer","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"kind","element":"transactionCoding","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":381.97,"expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-22-013017","document":"form4-12272022_101240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013017/form4-12272022_101240.xml","form_type":"4"}},{"id":2076416,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-12-27T17:55:49.000Z","date":"2022-12-22","kind":"disposition_to_issuer","acquired":false,"shares":33000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"kind","element":"transactionCoding","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":134.51,"expiration_date":"2027-05-15","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001415889-22-013017","document":"form4-12272022_101240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013017/form4-12272022_101240.xml","form_type":"4"}},{"id":2076415,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-12-27T17:55:49.000Z","date":"2022-12-22","kind":"disposition_to_issuer","acquired":false,"shares":30500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"kind","element":"transactionCoding","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":99.62,"expiration_date":"2026-05-24","underlying":"Common Stock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0001415889-22-013017","document":"form4-12272022_101240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013017/form4-12272022_101240.xml","form_type":"4"}},{"id":2076414,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-12-27T17:55:49.000Z","date":"2022-12-22","kind":"disposition_to_issuer","acquired":false,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"kind","element":"transactionCoding","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":66.25,"expiration_date":"2025-05-13","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-22-013017","document":"form4-12272022_101240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013017/form4-12272022_101240.xml","form_type":"4"}},{"id":2076413,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-12-27T17:55:49.000Z","date":"2022-12-22","kind":"disposition_to_issuer","acquired":false,"shares":85000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"kind","element":"transactionCoding","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option;"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"; and (2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":21.55,"expiration_date":"2024-05-14","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001415889-22-013017","document":"form4-12272022_101240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013017/form4-12272022_101240.xml","form_type":"4"}},{"id":2076412,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2022-12-27T17:55:49.000Z","date":"2022-12-22","kind":"disposition_to_issuer","acquired":false,"shares":243962,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the \"Merger Agreement\"), by and among the Issuer, Johnson & Johnson (\"Parent\") and Athos Merger Sub, Inc. (\"Merger Sub\"), pursuant to which, on December 22, 2022, Merger Sub was merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (each, an \"Issuer Share\") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the \"Cash Amount\"), plus (ii) one non-tradeable contingent value right (the \"CVR\"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement."},{"field":"shares","element":"transactionShares","label":"F3","text":"This number reflects unvested Company RSU Awards and shares of common stock. The Form 4 filed on December 20, 2022 for Michael Minogue inadvertently omitted unvested Company RSU\nAwards from the balance of non-derivative securities beneficially owned by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the \"Merger Agreement\"), by and among the Issuer, Johnson & Johnson (\"Parent\") and Athos Merger Sub, Inc. (\"Merger Sub\"), pursuant to which, on December 22, 2022, Merger Sub was merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (each, an \"Issuer Share\") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the \"Cash Amount\"), plus (ii) one non-tradeable contingent value right (the \"CVR\"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-013017","document":"form4-12272022_101240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013017/form4-12272022_101240.xml","form_type":"4"}},{"id":2076411,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2022-12-27T17:55:49.000Z","date":"2022-12-22","kind":"disposition_to_issuer","acquired":false,"shares":166670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the \"Merger Agreement\"), by and among the Issuer, Johnson & Johnson (\"Parent\") and Athos Merger Sub, Inc. (\"Merger Sub\"), pursuant to which, on December 22, 2022, Merger Sub was merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (each, an \"Issuer Share\") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the \"Cash Amount\"), plus (ii) one non-tradeable contingent value right (the \"CVR\"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, each award of restricted stock units of the Issuer, excluding any award of restricted stock units with vesting subject to performance-based conditions (\"Company RSU Award\"), outstanding as of immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company RSU Award and (B) the Cash Amount and (ii) one CVR per Issuer Share."},{"field":"shares","element":"transactionShares","label":"F3","text":"This number reflects unvested Company RSU Awards and shares of common stock. The Form 4 filed on December 20, 2022 for Michael Minogue inadvertently omitted unvested Company RSU\nAwards from the balance of non-derivative securities beneficially owned by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the \"Merger Agreement\"), by and among the Issuer, Johnson & Johnson (\"Parent\") and Athos Merger Sub, Inc. (\"Merger Sub\"), pursuant to which, on December 22, 2022, Merger Sub was merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (each, an \"Issuer Share\") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the \"Cash Amount\"), plus (ii) one non-tradeable contingent value right (the \"CVR\"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each award of restricted stock units of the Issuer, excluding any award of restricted stock units with vesting subject to performance-based conditions (\"Company RSU Award\"), outstanding as of immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company RSU Award and (B) the Cash Amount and (ii) one CVR per Issuer Share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-013017","document":"form4-12272022_101240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013017/form4-12272022_101240.xml","form_type":"4"}},{"id":2080351,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2022-12-20T16:02:54.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c)"},{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c)"}],"balance_after":136086,"source":{"system":"sec-edgar","filing":"0001415889-22-012840","document":"form4-12202022_091241.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922012840/form4-12202022_091241.xml","form_type":"4"}},{"id":2122873,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2022-11-08T16:30:37.000Z","date":"2022-11-05","kind":"tax_withholding","acquired":false,"shares":5164,"price":373.99,"value":1931284.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":248146,"source":{"system":"sec-edgar","filing":"0001415889-22-011180","document":"form4-11082022_091109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922011180/form4-11082022_091109.xml","form_type":"4"}},{"id":2146168,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2022-10-04T16:13:54.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":32,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c)"},{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c)"}],"balance_after":253310,"source":{"system":"sec-edgar","filing":"0001415889-22-010220","document":"form4-10042022_011027.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922010220/form4-10042022_011027.xml","form_type":"4"}},{"id":2212399,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-07-06T20:14:57.000Z","date":"2022-06-15","kind":"gift","acquired":true,"shares":808,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse.  The reporting person's spouse is a trustee of the trust."}],"balance_after":8921,"source":{"system":"sec-edgar","filing":"0001127602-22-018928","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760222018928/form4.xml","form_type":"4"}},{"id":2212398,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-07-06T20:14:57.000Z","date":"2022-06-15","kind":"gift","acquired":false,"shares":808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse.  The reporting person's spouse is a trustee of the trust."}],"balance_after":1009,"source":{"system":"sec-edgar","filing":"0001127602-22-018928","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760222018928/form4.xml","form_type":"4"}},{"id":2252174,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2022-05-31T17:26:04.000Z","date":"2022-05-29","kind":"tax_withholding","acquired":false,"shares":1563,"price":266.34,"value":416289.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F3","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":253278,"source":{"system":"sec-edgar","filing":"0001415889-22-005926","document":"form4-05312022_020547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922005926/form4-05312022_020547.xml","form_type":"4"}},{"id":2252173,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2022-05-31T17:26:04.000Z","date":"2022-05-29","kind":"tax_withholding","acquired":false,"shares":3906,"price":266.34,"value":1040324.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F3","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":254841,"source":{"system":"sec-edgar","filing":"0001415889-22-005926","document":"form4-05312022_020547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922005926/form4-05312022_020547.xml","form_type":"4"}},{"id":2252172,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2022-05-31T17:26:04.000Z","date":"2022-05-29","kind":"grant","acquired":true,"shares":8806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on May 29, 2020. One hundred percent of these restricted stock units vested on May 29, 2022 (into an equal number of shares of common stock) based on the issuer's achievement of a certain performance milestone."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on May 29, 2020. One hundred percent of these restricted stock units vested on May 29, 2022 (into an equal number of shares of common stock) based on the issuer's achievement of a certain performance milestone."}],"balance_after":258747,"source":{"system":"sec-edgar","filing":"0001415889-22-005926","document":"form4-05312022_020547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922005926/form4-05312022_020547.xml","form_type":"4"}},{"id":2252171,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2022-05-31T17:26:04.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":21393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 26, 2023, May 26, 2024 and May 26, 2025, so long as the reporting person continues to be employed by the issuer on the vesting dates."},{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 26, 2023, May 26, 2024 and May 26, 2025, so long as the reporting person continues to be employed by the issuer on the vesting dates."}],"balance_after":249941,"source":{"system":"sec-edgar","filing":"0001415889-22-005926","document":"form4-05312022_020547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922005926/form4-05312022_020547.xml","form_type":"4"}},{"id":2254549,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2022-05-27T16:05:40.000Z","date":"2022-05-25","kind":"tax_withholding","acquired":false,"shares":1258,"price":249.19,"value":313481.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":228548,"source":{"system":"sec-edgar","filing":"0001415889-22-005792","document":"form4-05272022_010503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922005792/form4-05272022_010503.xml","form_type":"4"}},{"id":2255493,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-26T20:10:15.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":1009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Annual equity award in the form of restricted stock units (\"RSUs\").  These RSUs vest in full on April 30, 2023 and are settled in shares of common stock on a one-for-one basis."}],"balance_after":1817,"source":{"system":"sec-edgar","filing":"0001127602-22-015765","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760222015765/form4.xml","form_type":"4"}},{"id":2255492,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-26T20:10:15.000Z","date":"2022-03-15","kind":"gift","acquired":true,"shares":3549,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse.  The reporting person's spouse is a trustee of the trust."}],"balance_after":8113,"source":{"system":"sec-edgar","filing":"0001127602-22-015765","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760222015765/form4.xml","form_type":"4"}},{"id":2255491,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-26T20:10:15.000Z","date":"2022-03-15","kind":"gift","acquired":false,"shares":3549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse.  The reporting person's spouse is a trustee of the trust."}],"balance_after":808,"source":{"system":"sec-edgar","filing":"0001127602-22-015765","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760222015765/form4.xml","form_type":"4"}},{"id":2309899,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2022-04-04T17:14:57.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":43,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c)."},{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c)."}],"balance_after":229806,"source":{"system":"sec-edgar","filing":"0001415889-22-003746","document":"form4-04042022_020436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922003746/form4-04042022_020436.xml","form_type":"4"}},{"id":2523882,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-11-05T16:30:34.000Z","date":"2021-11-03","kind":"tax_withholding","acquired":false,"shares":5158,"price":349.76,"value":1804062.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F5","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":229763,"source":{"system":"sec-edgar","filing":"0001179110-21-009903","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021009903/edgar.xml","form_type":"4"}},{"id":2523881,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-11-05T16:30:34.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":23250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on November 5, 2020. One half of these restricted stock units vested on November 3, 2021 (into an equal number of shares of common stock) based on the issuer's achievement of a certain performance milestone with the remaining vesting on the second anniversary of the date of grant as long as the reporting person continues to be employed by the issuer on the vesting dates."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on November 5, 2020. One half of these restricted stock units vested on November 3, 2021 (into an equal number of shares of common stock) based on the issuer's achievement of a certain performance milestone with the remaining vesting on the second anniversary of the date of grant as long as the reporting person continues to be employed by the issuer on the vesting dates."}],"balance_after":234921,"source":{"system":"sec-edgar","filing":"0001179110-21-009903","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021009903/edgar.xml","form_type":"4"}},{"id":2553297,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-10-04T17:19:45.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":36,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c)."},{"field":"shares","element":"transactionShares","label":"F4","text":"These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c)."}],"balance_after":211671,"source":{"system":"sec-edgar","filing":"0001179110-21-009164","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021009164/edgar.xml","form_type":"4"}},{"id":2591601,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-25T16:37:50.000Z","date":"2021-08-23","kind":"disposition_to_issuer","acquired":false,"shares":3492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6."}],"balance_after":0,"derivative":{"exercise_price":23.15,"exercise_date":"2014-05-14","expiration_date":"2023-05-14","underlying":"Common stock","underlying_shares":3492},"source":{"system":"sec-edgar","filing":"0001179110-21-008415","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021008415/edgar.xml","form_type":"4"}},{"id":2591600,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-08-25T16:37:50.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":3492,"price":350,"value":1222200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the sale price of the transactions on the reported date at $350.0000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":211635,"source":{"system":"sec-edgar","filing":"0001179110-21-008415","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021008415/edgar.xml","form_type":"4"}},{"id":2591599,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-08-25T16:37:50.000Z","date":"2021-08-23","kind":"exercise","acquired":true,"shares":3492,"price":23.15,"value":80839.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."}],"balance_after":215127,"source":{"system":"sec-edgar","filing":"0001179110-21-008415","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021008415/edgar.xml","form_type":"4"}},{"id":2609347,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-10T17:07:18.000Z","date":"2021-08-06","kind":"disposition_to_issuer","acquired":false,"shares":31508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan."},{"field":"date","element":"transactionDate","label":"F8","text":"The exercise of stock options pursuant to the reporting owners 10b5-1 plan occurred over multiple dates.  This date represents the earliest exercise reported on this Form. Please refer to Table I for the each of the reported exercise dates."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6."}],"balance_after":3492,"derivative":{"exercise_price":23.15,"exercise_date":"2014-05-14","expiration_date":"2023-05-14","underlying":"Common stock","underlying_shares":31508},"source":{"system":"sec-edgar","filing":"0001179110-21-008088","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021008088/edgar.xml","form_type":"4"}},{"id":2609346,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-08-10T17:07:18.000Z","date":"2021-08-09","kind":"sale","acquired":false,"shares":7037,"price":350,"value":2462950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the sale price of the transactions on the reported date at $350.0000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":211635,"source":{"system":"sec-edgar","filing":"0001179110-21-008088","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021008088/edgar.xml","form_type":"4"}},{"id":2609345,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-08-10T17:07:18.000Z","date":"2021-08-09","kind":"exercise","acquired":true,"shares":7037,"price":23.15,"value":162906.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."}],"balance_after":218672,"source":{"system":"sec-edgar","filing":"0001179110-21-008088","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021008088/edgar.xml","form_type":"4"}},{"id":2609344,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-08-10T17:07:18.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":24471,"price":350,"value":8564850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the sale price of the transactions on the reported date at $350.0000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":211635,"source":{"system":"sec-edgar","filing":"0001179110-21-008088","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021008088/edgar.xml","form_type":"4"}},{"id":2609343,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-08-10T17:07:18.000Z","date":"2021-08-06","kind":"exercise","acquired":true,"shares":24471,"price":23.15,"value":566503.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."}],"balance_after":236106,"source":{"system":"sec-edgar","filing":"0001179110-21-008088","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021008088/edgar.xml","form_type":"4"}},{"id":2612282,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-06T16:16:05.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6."}],"balance_after":35000,"derivative":{"exercise_price":23.15,"exercise_date":"2014-05-14","expiration_date":"2023-05-14","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-21-007996","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021007996/edgar.xml","form_type":"4"}},{"id":2612281,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-08-06T16:16:05.000Z","date":"2021-08-05","kind":"sale","acquired":false,"shares":1000,"price":344.43,"value":344430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"This price represents the sale price of the transactions on the reported date at $344.4270. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":211635,"source":{"system":"sec-edgar","filing":"0001179110-21-007996","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021007996/edgar.xml","form_type":"4"}},{"id":2612280,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-08-06T16:16:05.000Z","date":"2021-08-05","kind":"sale","acquired":false,"shares":400,"price":346.08,"value":138432.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This price represents the sale price of the transactions on the reported date at $346.0750. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":212635,"source":{"system":"sec-edgar","filing":"0001179110-21-007996","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021007996/edgar.xml","form_type":"4"}},{"id":2612279,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-08-06T16:16:05.000Z","date":"2021-08-05","kind":"sale","acquired":false,"shares":500,"price":345.33,"value":172665.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This price represents the sale price of the transactions on the reported date at $345.3314. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":213035,"source":{"system":"sec-edgar","filing":"0001179110-21-007996","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021007996/edgar.xml","form_type":"4"}},{"id":2612278,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-08-06T16:16:05.000Z","date":"2021-08-05","kind":"sale","acquired":false,"shares":1500,"price":343.32,"value":514980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This price represents the sale price of the transactions on the reported date at $3343.3223. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":213535,"source":{"system":"sec-edgar","filing":"0001179110-21-007996","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021007996/edgar.xml","form_type":"4"}},{"id":2612277,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-08-06T16:16:05.000Z","date":"2021-08-05","kind":"sale","acquired":false,"shares":1335,"price":342.48,"value":457210.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This price represents the sale price of the transactions on the reported date at $342.4849. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":215035,"source":{"system":"sec-edgar","filing":"0001179110-21-007996","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021007996/edgar.xml","form_type":"4"}},{"id":2612276,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-08-06T16:16:05.000Z","date":"2021-08-05","kind":"sale","acquired":false,"shares":5378,"price":341.44,"value":1836264.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This price represents the sale price of the transactions on the reported date at $341.4448. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":216370,"source":{"system":"sec-edgar","filing":"0001179110-21-007996","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021007996/edgar.xml","form_type":"4"}},{"id":2612275,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-08-06T16:16:05.000Z","date":"2021-08-05","kind":"sale","acquired":false,"shares":14887,"price":340.27,"value":5065599.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the sale price of the transactions on the reported date at $340.2661. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":221748,"source":{"system":"sec-edgar","filing":"0001179110-21-007996","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021007996/edgar.xml","form_type":"4"}},{"id":2612274,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-08-06T16:16:05.000Z","date":"2021-08-05","kind":"exercise","acquired":true,"shares":25000,"price":23.15,"value":578750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."}],"balance_after":236635,"source":{"system":"sec-edgar","filing":"0001179110-21-007996","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021007996/edgar.xml","form_type":"4"}},{"id":2657952,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-23T16:05:36.000Z","date":"2021-06-21","kind":"disposition_to_issuer","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6."}],"balance_after":60000,"derivative":{"exercise_price":23.15,"exercise_date":"2014-05-14","expiration_date":"2023-05-14","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-21-006974","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021006974/edgar.xml","form_type":"4"}},{"id":2657951,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-06-23T16:05:36.000Z","date":"2021-06-21","kind":"sale","acquired":false,"shares":5343,"price":326.04,"value":1742031.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This price represents the sale price of the transactions on the reported date at $326.0398. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":211635,"source":{"system":"sec-edgar","filing":"0001179110-21-006974","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021006974/edgar.xml","form_type":"4"}},{"id":2657950,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-06-23T16:05:36.000Z","date":"2021-06-21","kind":"sale","acquired":false,"shares":19657,"price":325.16,"value":6391670.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the sale price of the transactions on the reported date at $325.1555. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":216978,"source":{"system":"sec-edgar","filing":"0001179110-21-006974","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021006974/edgar.xml","form_type":"4"}},{"id":2657949,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-06-23T16:05:36.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":25000,"price":23.15,"value":578750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."}],"balance_after":236635,"source":{"system":"sec-edgar","filing":"0001179110-21-006974","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021006974/edgar.xml","form_type":"4"}},{"id":2687832,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-06-02T16:33:42.000Z","date":"2021-05-29","kind":"tax_withholding","acquired":false,"shares":1563,"price":284.58,"value":444798.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F5","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":211635,"source":{"system":"sec-edgar","filing":"0001179110-21-006227","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021006227/edgar.xml","form_type":"4"}},{"id":2691658,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-28T20:09:53.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual equity award in the form of restricted stock units (\"RSUs\"). RSUs vest in full on April 30, 2022 and are settled in shares of common stock on a one-for-one basis."}],"balance_after":4357,"source":{"system":"sec-edgar","filing":"0001127602-21-018311","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760221018311/form4.xml","form_type":"4"}},{"id":2694303,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-27T16:46:56.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6."}],"balance_after":30000,"derivative":{"exercise_price":283.88,"exercise_date":"2022-05-25","expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001179110-21-006014","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021006014/edgar.xml","form_type":"4"}},{"id":2694302,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-05-27T16:46:56.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":8503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 25,2022, May 25, 2023 and May 25, 2024, so long as the reporting person continues to be employed by the issuer on the vesting dates."},{"field":"shares","element":"transactionShares","label":"F5","text":"Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 25,2022, May 25, 2023 and May 25, 2024, so long as the reporting person continues to be employed by the issuer on the vesting dates."}],"balance_after":213198,"source":{"system":"sec-edgar","filing":"0001179110-21-006014","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021006014/edgar.xml","form_type":"4"}},{"id":2709384,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-05-18T17:10:39.000Z","date":"2021-05-16","kind":"tax_withholding","acquired":false,"shares":4531,"price":268.56,"value":1216845.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F5","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":204695,"source":{"system":"sec-edgar","filing":"0001179110-21-005516","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021005516/edgar.xml","form_type":"4"}},{"id":2709383,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-05-18T17:10:39.000Z","date":"2021-05-16","kind":"tax_withholding","acquired":false,"shares":1627,"price":268.56,"value":436947.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F5","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":209226,"source":{"system":"sec-edgar","filing":"0001179110-21-005516","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021005516/edgar.xml","form_type":"4"}},{"id":2762708,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2021-04-02T16:25:18.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":52,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c)."},{"field":"shares","element":"transactionShares","label":"F5","text":"These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c)."}],"balance_after":210853,"source":{"system":"sec-edgar","filing":"0001179110-21-004096","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021004096/edgar.xml","form_type":"4"}},{"id":3017435,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-10-02T16:47:12.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":55,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c)."},{"field":"shares","element":"transactionShares","label":"F5","text":"These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c)."}],"balance_after":210801,"source":{"system":"sec-edgar","filing":"0001179110-20-010184","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020010184/edgar.xml","form_type":"4"}},{"id":3049217,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-24T17:45:44.000Z","date":"2020-08-20","kind":"exercise","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6."}],"balance_after":0,"derivative":{"exercise_price":22.44,"exercise_date":"2013-05-22","expiration_date":"2022-05-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001179110-20-009257","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020009257/edgar.xml","form_type":"4"}},{"id":3049216,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-08-24T17:45:44.000Z","date":"2020-08-19","kind":"gift","acquired":true,"shares":20883,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust - A"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse. The reporting person's spouse is a trustee of the trust."},{"field":"shares","element":"transactionShares","label":"F8","text":"This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse. The reporting person's spouse is a trustee of the trust."}],"balance_after":52555,"source":{"system":"sec-edgar","filing":"0001179110-20-009257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020009257/edgar.xml","form_type":"4"}},{"id":3049215,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-08-24T17:45:44.000Z","date":"2020-08-21","kind":"sale","acquired":false,"shares":100,"price":310.1,"value":31010.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $304.6400 and $314.8000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":210746,"source":{"system":"sec-edgar","filing":"0001179110-20-009257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020009257/edgar.xml","form_type":"4"}},{"id":3049214,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-08-24T17:45:44.000Z","date":"2020-08-21","kind":"sale","acquired":false,"shares":4876,"price":307.96,"value":1501612.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $304.6400 and $314.8000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":210846,"source":{"system":"sec-edgar","filing":"0001179110-20-009257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020009257/edgar.xml","form_type":"4"}},{"id":3049213,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-08-24T17:45:44.000Z","date":"2020-08-21","kind":"sale","acquired":false,"shares":11189,"price":307.24,"value":3437708.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $304.6400 and $314.8000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":215722,"source":{"system":"sec-edgar","filing":"0001179110-20-009257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020009257/edgar.xml","form_type":"4"}},{"id":3049212,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-08-24T17:45:44.000Z","date":"2020-08-21","kind":"sale","acquired":false,"shares":9235,"price":306.11,"value":2826925.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $304.6400 and $314.8000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":226911,"source":{"system":"sec-edgar","filing":"0001179110-20-009257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020009257/edgar.xml","form_type":"4"}},{"id":3049211,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-08-24T17:45:44.000Z","date":"2020-08-21","kind":"sale","acquired":false,"shares":14600,"price":305.2,"value":4455920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $304.6400 and $314.8000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":236146,"source":{"system":"sec-edgar","filing":"0001179110-20-009257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020009257/edgar.xml","form_type":"4"}},{"id":3049210,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-08-24T17:45:44.000Z","date":"2020-08-21","kind":"exercise","acquired":true,"shares":40000,"price":22.44,"value":897600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."}],"balance_after":250746,"source":{"system":"sec-edgar","filing":"0001179110-20-009257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020009257/edgar.xml","form_type":"4"}},{"id":3049209,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-08-24T17:45:44.000Z","date":"2020-08-20","kind":"sale","acquired":false,"shares":2715,"price":314.13,"value":852862.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $304.6400 and $314.8000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":210746,"source":{"system":"sec-edgar","filing":"0001179110-20-009257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020009257/edgar.xml","form_type":"4"}},{"id":3049208,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-08-24T17:45:44.000Z","date":"2020-08-20","kind":"sale","acquired":false,"shares":6254,"price":313.23,"value":1958940.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $304.6400 and $314.8000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":213461,"source":{"system":"sec-edgar","filing":"0001179110-20-009257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020009257/edgar.xml","form_type":"4"}},{"id":3049207,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-08-24T17:45:44.000Z","date":"2020-08-20","kind":"sale","acquired":false,"shares":5596,"price":312.08,"value":1746399.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $304.6400 and $314.8000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":219715,"source":{"system":"sec-edgar","filing":"0001179110-20-009257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020009257/edgar.xml","form_type":"4"}},{"id":3049206,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-08-24T17:45:44.000Z","date":"2020-08-20","kind":"sale","acquired":false,"shares":14196,"price":311.09,"value":4416233.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $304.6400 and $314.8000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":225311,"source":{"system":"sec-edgar","filing":"0001179110-20-009257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020009257/edgar.xml","form_type":"4"}},{"id":3049205,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-08-24T17:45:44.000Z","date":"2020-08-20","kind":"sale","acquired":false,"shares":27480,"price":310.09,"value":8521273.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $304.6400 and $314.8000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":239507,"source":{"system":"sec-edgar","filing":"0001179110-20-009257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020009257/edgar.xml","form_type":"4"}},{"id":3049204,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-08-24T17:45:44.000Z","date":"2020-08-20","kind":"sale","acquired":false,"shares":3759,"price":309.4,"value":1163034.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F6","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $304.6400 and $314.8000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":266987,"source":{"system":"sec-edgar","filing":"0001179110-20-009257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020009257/edgar.xml","form_type":"4"}},{"id":3049203,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-08-24T17:45:44.000Z","date":"2020-08-20","kind":"exercise","acquired":true,"shares":60000,"price":22.44,"value":1346400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F5","text":"Exercise of stock options pursuant to reporting owners 10b5-1 plan."}],"balance_after":270746,"source":{"system":"sec-edgar","filing":"0001179110-20-009257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020009257/edgar.xml","form_type":"4"}},{"id":3049202,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-08-24T17:45:44.000Z","date":"2020-08-19","kind":"gift","acquired":false,"shares":20883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse. The reporting person's spouse is a trustee of the trust."},{"field":"shares","element":"transactionShares","label":"F8","text":"This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse. The reporting person's spouse is a trustee of the trust."}],"balance_after":210746,"source":{"system":"sec-edgar","filing":"0001179110-20-009257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020009257/edgar.xml","form_type":"4"}},{"id":3128062,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-02T20:35:02.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":20898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6."}],"balance_after":20898,"derivative":{"exercise_price":223.9,"exercise_date":"2021-05-29","expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":20898},"source":{"system":"sec-edgar","filing":"0001179110-20-006838","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020006838/edgar.xml","form_type":"4"}},{"id":3128061,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-06-02T20:35:02.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":10567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 29, 2021, May 29, 2022 and May 29, 2023, so long as the reporting person continues to be employed by the issuer on the vesting dates."},{"field":"shares","element":"transactionShares","label":"F5","text":"Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 29, 2021, May 29, 2022 and May 29, 2023, so long as the reporting person continues to be employed by the issuer on the vesting dates."}],"balance_after":231629,"source":{"system":"sec-edgar","filing":"0001179110-20-006838","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020006838/edgar.xml","form_type":"4"}},{"id":3129300,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-06-01T21:00:27.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":1029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual equity award in the form of restricted stock units (\"RSUs\").  RSUs vest in full on April 30, 2021 and are settled in shares of common stock on a one-for-one basis."}],"balance_after":3549,"source":{"system":"sec-edgar","filing":"0001127602-20-018249","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760220018249/form4.xml","form_type":"4"}},{"id":3144239,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-05-19T16:32:45.000Z","date":"2020-05-16","kind":"tax_withholding","acquired":false,"shares":4546,"price":184.92,"value":840646.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F5","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":221062,"source":{"system":"sec-edgar","filing":"0001179110-20-006306","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020006306/edgar.xml","form_type":"4"}},{"id":3144238,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-05-19T16:32:45.000Z","date":"2020-05-16","kind":"tax_withholding","acquired":false,"shares":1632,"price":184.92,"value":301789.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F5","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":225608,"source":{"system":"sec-edgar","filing":"0001179110-20-006306","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020006306/edgar.xml","form_type":"4"}},{"id":3144237,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-05-19T16:32:45.000Z","date":"2020-05-15","kind":"tax_withholding","acquired":false,"shares":2063,"price":184.27,"value":380149.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F5","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":227240,"source":{"system":"sec-edgar","filing":"0001179110-20-006306","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020006306/edgar.xml","form_type":"4"}},{"id":3144236,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-05-19T16:32:45.000Z","date":"2020-05-15","kind":"tax_withholding","acquired":false,"shares":8506,"price":184.27,"value":1567400.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F5","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":229303,"source":{"system":"sec-edgar","filing":"0001179110-20-006306","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020006306/edgar.xml","form_type":"4"}},{"id":3187840,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":45352,"kind":"person","name":"MINOGUE MICHAEL R","position":1,"cik":"0001286370","reported_name":"MINOGUE MICHAEL R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President, CEO"}}],"security":"Common Stock $.01 par value","published_at":"2020-04-02T17:11:34.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":93,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c)."},{"field":"shares","element":"transactionShares","label":"F5","text":"These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c)."}],"balance_after":237809,"source":{"system":"sec-edgar","filing":"0001179110-20-004525","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020004525/edgar.xml","form_type":"4"}}],"next_cursor":"2020-04-02T17:11:34.000000Z,3187840"}